IC
TXG icon

Inscription Capital’s 10x Genomics TXG Stock Holding History

Inscription Capital’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.01M Sell
52,322
-17,183
-25% -$450K 0.18% 100
2026
Q1 		$1.48M Sell
69,505
-10,831
-13% -$217K 0.16% 113
2025
Q4 		$1.31M Sell
80,336
-15,678
-16% -$237K 0.13% 135
2025
Q3 		$1.12M Buy
96,014
+59,305
+162% +$773K 0.12% 163
2025
Q2 		$425K Buy
+36,709
New +$335K 0.06% 260

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Inscription Capital's TXG Position: Q2 2026 in Review

Inscription Capital reduced its 10x Genomics (TXG) stake by 25% in Q2 2026, selling an estimated $450K and leaving 52,322 shares worth $2.01M. The position accounts for 0.18% of the portfolio, ranked #100.

Inscription Capital first reported a position in TXG in Q2 2025 and has held it in 5 quarters since. 390 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Inscription Capital held 52,322 shares of 10x Genomics worth $2.01M as of Q2 2026.
  • Inscription Capital sold 17,183 10x Genomics shares in Q2 2026, an estimated $450K.
  • 10x Genomics made up 0.18% of Inscription Capital's portfolio in Q2 2026, its #100 holding.
  • Inscription Capital first reported a position in 10x Genomics in Q2 2025 and has held it in 5 quarters since.
  • 390 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Inscription Capital's 13F filing for Q2 2026, filed 13 Aug 2026.